Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Company profile: NeoImmuneTech

Role of KOL influence

Illuminating Real-Time Patient Needs Through Socially Driven Insights

6th Annual 3D Cell Culture Conference

Increasing sustainability in pharma requires an industry-wide effort

lung diseases

Lungs-16-9

News/ News/ R&D

Cantex secures license to develop small molecule-drug for inflammatory lung diseases

Eloise McLennan asthma, infection, lung diseases, pharma, small molecule 0 Comment

Clinical stage pharmaceutical company Cantex Pharmaceuticals has obtained a global licence from Harvard University’s Office of Technology Development

X

Cantex secures license to develop small molecule-drug for inflammatory lung diseases

https://pharmaphorum.com/news/cantex-secures-license-to-develop-small-molecule-drug-for-inflammatory-lung-diseases/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

MHRA, NHS England make available new prostate cancer treatment
Genomic testing 'should be offered to all cancer patients in Scotland'
AstraZeneca, C4XD sign exclusive $402 million global licence
LEO Pharma's Adtralza approved by MHRA, EC for adolescent atopic dermatitis
Owkin taps Linux Foundation to open-source its AI learning software

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com